Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1537500

registered interest
date	31/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made any preparations to introduce antibody testing before Christmas 2022 for immunocompromised and immunosuppressed patients who may not mount a full response to Covid vaccines.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	74935
answer	answer is ministerial correction date of answer 04/11/2022 answer text <p>The Antivirals and Therapeutics Taskforce is exploring options for a pilot study to test antibody levels in immunosuppressed patients to provide clinical evidence of a potential protective vaccine response. This could inform a wider testing programme identifying those who have mounted a protective antibody response following vaccination and provide more informed advice.</p><p>No specific cost estimate has yet been made. However, officials are in discussions with experts in this area and further information will be available in due course.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 74936 question first answered 04/11/2022 13:25:49 answering member 4423 label Biography information for Will Quince
tabling member	4769 label Biography information for Daisy Cooper

1537501

registered interest
date	31/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost of providing antibody testing to the estimated 500,000 immunocompromised and immunosuppressed patients who may not mount a full response to the covid-19 vaccines.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	74936
answer	answer is ministerial correction date of answer 04/11/2022 answer text <p>The Antivirals and Therapeutics Taskforce is exploring options for a pilot study to test antibody levels in immunosuppressed patients to provide clinical evidence of a potential protective vaccine response. This could inform a wider testing programme identifying those who have mounted a protective antibody response following vaccination and provide more informed advice.</p><p>No specific cost estimate has yet been made. However, officials are in discussions with experts in this area and further information will be available in due course.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 74935 question first answered 04/11/2022 13:25:49 answering member 4423 label Biography information for Will Quince
tabling member	4769 label Biography information for Daisy Cooper

1537303

registered interest
date	31/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that healthcare providers administering COVID-19 vaccines have access to the full portfolio of vaccines purchased by the Government and available in the UK.
tabling member printed	Baroness Masham of Ilton
uin	HL3058
answer	answer is ministerial correction date of answer 10/11/2022 answer text <p>In the United Kingdom, the COVID-19 vaccines currently in use have been authorised by the independent regulator, the Medicines and Healthcare products Regulatory Authority. The majority of people will be offered a vaccine manufactured by Pfizer/BioNTech or Moderna. However, for those clinically intolerant to these MRNA vaccines, the Nuvaxovid COVID-19 vaccine manufactured by Novavax is also available. All vaccination centres order supplies according to anticipated requirements. NHS England has asked regional teams to nominate sites in England to administer the Nuvaxovid vaccine.</p> answering member printed Lord Markham question first answered 10/11/2022 16:37:12 answering member 4948 label Biography information for Lord Markham
tabling member	1850 label Biography information for Baroness Masham of Ilton